The challenge of growing up HIV infected in resource-limited settings

Size: px
Start display at page:

Download "The challenge of growing up HIV infected in resource-limited settings"

Transcription

1 The challenge of growing up HIV infected in resource-limited settings Dr. Philippa Musoke Department of Paediatrics Makerere Unversity Kampala Uganda and MUJHU Research Collaboration

2 Outline Paediatric HIV epidemiology Challenges : HIV Diagnosis Morbidity and mortality Malnutrition Access and response to Antiretroviral therapy

3 Paediatric HIV epidemiology 2.3 million HIV infected children worldwide 400,000 infants infected each year 90% are infected through Mother to Child Transmission 90% are found in sub- Saharan Africa UNAIDS report 2010

4 Data from African Perinatal Prevention Trials from Breastfeeding HIV Transmission Study Meta-Analysis: Mortality in Infected Children was 53% at 2 years Median survival 1.6 years By age 2.5 years, 60% mortality Courtesy MG Fowler Newell et al. Lancet 2004

5 Early Cessation of Breastfeeding Was Particularly Harmful for Children Who Became HIV-Infected Survival of HIV-infected Children with Positive Results before Age 4 Months by Group Assignment (Abrupt vs Standard Weaning) Continued Breastfeeding Stopped Breastfeeding p = 0.01 Kuhn L et al. NEJM 2008

6 Treatment of Pediatric HIV Infection in Resource-Poor Countries is Often Significantly Delayed, Resulting in Excess Mortality Lack of identification of HIV infection in pregnancy Lack of access to HIV DNA PCR testing using DBS Lack of appropriate pediatric formulations NVP exposure for PMTCT complicates 1 st line ART

7 Malnutrition and HIV infection Most HIV infected children are malnourished Median wt- and ht-for-age z-score <-2 In 30 different studies of children on ART (Sutclife) 30 50% of children hospitalized with severe acute malnutrition (SAM) are HIV+ (Bachou H) Mortality of children with HIV and SAM is 4 times higher than those with SAM alone (30% vs 8%) (Fergusson P) Severe pneumonia and SAM were risk factors for death in hospitalized children (Preidis GA J Pediatr 2011) Fergusson P, et al Trans R Soc Trop Med Hyg 2008; Sutcliffe et al CG, Bachou H et al. Nutr J 2006,

8 Severe malnutrition post ART ARROW trial Compared children who were hospitalized with SAM ( both edematous and non-edematous types) and those not hospitalized 39/1207 (3.2%) were hospitalized (20 with edema) Median days after ART initiation = 27 days 28 days (14-36) marasmus and 26 days (14-56) for kwashiorkor Children with advanced disease n =220 (CD4% & WAZ<-3 SD) 7.3% (95% CI ) kwashiorkor (K) 3.2 % (95% CI ) marasmus (M) Mortality at 24 wks - 32% marasmus; 20% kwashiorkor - compared to 1.7 % for non hospitalized children Prendergast A et al AIDS 2011

9 Increased Malaria morbidity 542 children diagnosed with P falciparum malaria and admitted to hospital, Western Kenya HIV infected (n=24) HIV exposed (n=112) HIV negative (n=406) P value Mean Haemoglobin 5.2 (2.9) 6.2 (2.7) 6.9 (3.5) Hb < 6g/dl (%) 64 % 41% * 35% # * # Mortality n(%) 8(33.2) 6(5.4) 13(3.2) <0.001 Davenport GC et al. Am J Hematol. 2010

10 Increase incidence of Tuberculosis disease in HIV infected children Cohort of south African children randomized to INH or placebo(548 HIV+ and 804 HIV- infants) (Smith) 121 TB cases /1000 child-years (CI ) HIV+ 41 TB cases/1000 child-years (CI 31-52) HIV No benefit of INH prophylaxis IRIS (20-30% of children on ART) 29% of IRIS events in children were TB Uganda (Orikiriiza) 71% % of IRIS events in children were TB S.Africa (Mahdi) Majority BCG adenitis Mahdi SA et al NEJM 2011; Orikiriiza J et al AIDS 2009; Smith K et al AIDS 2009

11 Challenge of TB/HIV co-infection HIV infected children at higher risk of developing TB disease More difficult to diagnose TB in HIV co-infected children Interaction of anti-tb medications and ARVs (Rifampicin lowers blood levels of NVP and Lopinavir/ritonavir) Increasing the NVP to 200mg/m2/day or boosting the LPV/r with additional ritonavir is recommended WHO ART guidelines for infants and children 2010

12 Percentage of children accessing Antiretroviral therapy World wide - 38% of HIV infected children eligible for ART access therapy (Adults 43%) Sub-Saharan Africa 35 % Latin America and Caribbean 76% South Africa and Botswana ART coverage for children > adults Botswana 80% S Africa 65 % UNAIDS report 2010

13 First line regimen in children from 36 low and middle income countries (UNAIDS report 2008)

14 Antiretroviral treatment response in Resource-Limited Settings 3936 children aged < 5 yrs initiated HAART (MSF ) 2971 were alive at time of analysis 90% from Africa and rest from Asia 50% were months of age Median duration on ART was 10.5 months ( ) Probability of remaining in care after 36 mths=0.75 Mortality-6.3% (249) Lost to FU-10.3% (407) 55% of all deaths occurred in the 1st 3-6 mths on ART 151 (3.8%) experienced severe drug toxicity Sauvageot D et al Pediatr 2010

15 Long term response to ART Thailand mortality: age < 1yr; CD4% < 5%; Wt-for-ht z score <-2 N=578 Collins I J et al CID 2010

16 Monitoring response to ART in RLS Weight measurement Weight gain is an early sign of treatment response but does not predict treatment success CD4 cell count Most children have a good CD4 response on ART May be available at regional centers Viral load HIV-RNA Not available in most RLS Is VL needed for all children on ART(ARROW trial) Sutcliffe CG et al Lancet Inf Dis 2008

17 Challenges of ART in children 1. Splitting adult FDC tablets may be effective but not recommended now (O Brien DP et al AIDS 2006) 4. PI syrups require refrigeration (Kaletra) 2. Adherence to syrups less than tablets (Nahirya P - Abstract IAC 2010) 3. Need for dose adjustments as the child grows Biadgilign S et al BMC Ped 2010 Vreeman RC et al PIDJ 2008 Nabukeera Barungi et al

18 Burden of the limited paediatric antiretroviral drug formulations Months supply of ARV syrups Fixed dose combination less bulky and easier to administer (single tabs vs FDC) Photograph - Arrow Trial Uganda courtesy Bethany Naidoo

19 Prevalence of Immune Reconstitution Syndrome Cohort of 162 Ugandan children on ART 38% ( CI 31-36) developed IRIS Median Age 6 years (IQR years) Tuberculosis was the most common event=29% Others - pruritic papular eruptions (PPE), candida and pneumonia Factors associated with IRIS Male sex OR 2.96 ( ) Pre-ART CD4% OR 4.39 ( ) CD8+ < 1000 cells/ul OR 4.56 ( ) Cough(current) OR 4.30 ( ) Orikiriiza J et al AIDS 2010

20 Thailand Lipodystrophy in Resource-Limited Settings 90 HIV+ children on ART (NNRTI) Lipodystrophy 9%, 47% and 65% at 48, 96 and 144 weeks 11% dyslipidemia India 52 HIV + children ( 25 ART non PI, 27 not on ART) Only 4 had cholesterol 2 lipoatrophy, 3 triglycerides ( follow up 3 months) Brazil 30 children (30% on PI) median duration on ART 28 mths 53% lipodystrophy, 60% dyslipidemia Aurpibul L et al Antivir Ther 2007; Parakh A Indian J Pediatr; Sarni RO et al J Pediatr

21 ADOLESCENTS - cause of acute hospitalization in Zimbabwe n= 139 Risk factors for death pubertal delay and other chronic illness Cause of admission Bacterial infections (pneumonia, bacteraemia, etc) HIV infected N=139 (%) 65 (47) Mycobacterial disease (MTB)* Fungal disease (Cryptococosis* and candida) 25 (18) 35 (25) Wasting syndrome* 15 (11) Non-infectious(severe anemia) 53 (48) * Top 3 causes of death Ferrand R et al PLoS 2010

22 Challenges in Adolescent HIV Care Knowledge of HIV infection Linking to (and retaining in) health care Accepting (and adhering to) therapy Mental health issues Complexities of transition to adult care High risk population for HIV transmission 40-60% of HIV-infected adolescents continue to engage in unprotected sex Rice E et al. Prospect Sex Repro Health 2006;38:162-7 Murphy DA et al. J Adol Health 2001;29S:57-63 Sturdevant MS et al. J Adol Health 2001;29S:64-71 Kadivar H et al. AIDS Care 2006;18:544-9 Rotheram-Borus M et al. J Adoles 2001;24: Lightfoot M et al. Am J Health Behav 2005;29:

23 Psychosocial challenges Multiple caretakers if orphans Children become the caretakers to sick parents Stigmatization in school Depression and disclosure Poverty Lack of school fees Transport Skovdal M et al Global Health 2009

24 Conclusion Despite multiple challenges, HIV infected children can survive and their quality of life improved by: Early infant diagnosis using DBS Nutritional support including EBF Early initiation of ART and adherence support Appropriate ART formulations Counseling and psychosocial support There is a need for overall improvement in child health and survival if WE.

25 A 12 year old girl before ART and one year later

26 GOD BLESS, THANK YOU

27 Acknowlegements Addy Kekitiinwa Linda Barlow Mosha Mary Glenn Fowler Elaine Abrams Children and caretakers in our care and treatment programs

Scaling up priority HIV/AIDS interventions in the health sector

Scaling up priority HIV/AIDS interventions in the health sector TOWARDS UNIVERSAL ACCESS? Scaling up priority HIV/AIDS interventions in the health sector Yves Souteyrand, WHO October 2011 Towards universal access targets UN General Assembly High level Meeting June

More information

Current challenges of paediatric HIV care Experiences in Sub-Saharan Africa. Dr. Elizabeth Obimbo University of Nairobi Nairobi, Kenya

Current challenges of paediatric HIV care Experiences in Sub-Saharan Africa. Dr. Elizabeth Obimbo University of Nairobi Nairobi, Kenya Current challenges of paediatric HIV care Experiences in Sub-Saharan Africa Dr. Elizabeth Obimbo University of Nairobi Nairobi, Kenya Current Challenges of Paediatric HIV Care What is Happening in the

More information

Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014

Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014 Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014 Outline Background History of prevention of mother to child

More information

Improving accessibility to antiretroviral drugs: A south-south collaboration

Improving accessibility to antiretroviral drugs: A south-south collaboration Improving accessibility to antiretroviral drugs: A south-south collaboration Jaideep A Gogtay MD Cipla Ltd Mumbai jgogtay@cipla.com Adults and children estimated to be living with HIV at the end of 2000

More information

THE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES 2010

THE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES 2010 THE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES 2010 The South African Antiretroviral Treatment Guidelines 2010 Goals of the programme Achieve best health outcomes in the most cost-efficient manner

More information

Intira Jeannie Collins, Ruth Goodall, Colette Smith and Kara Wools-Kaloustian for the CIPHER Duration of First-Line Project Team.

Intira Jeannie Collins, Ruth Goodall, Colette Smith and Kara Wools-Kaloustian for the CIPHER Duration of First-Line Project Team. Switch to second-line ART in HIV-infected children: a Collaborative Initiative for Paediatric HIV Education & Research (CIPHER) Global Cohort Collaboration analysis Intira Jeannie Collins, Ruth Goodall,

More information

PAEDIATRIC TREATMENT& FORMULATIONS

PAEDIATRIC TREATMENT& FORMULATIONS PAEDIATRIC TREATMENT& FORMULATIONS DR.SABRINA BAKEERA-KITAKA DEPARTMENT OF PAEDIATRICS & CHILD HEALTH MAKERERE UNIVERSITY,COLLEGE OF HEALTH SCIENCES 6 th INTEREST MEETING,8-11,MAY 2012,MOMBASA Differences

More information

Paediatric HIV Drug Resistance 26th-International-Workshop-on-HIV-Drug-Resistance-programme [2].tiff

Paediatric HIV Drug Resistance 26th-International-Workshop-on-HIV-Drug-Resistance-programme [2].tiff Paediatric HIV Drug Resistance 26th-International-Workshop-on-HIV-Drug-Resistance-programme- 20171031[2].tiff Mo Archary King Edward VIII Hospital / UKZN Paediatric Infectious Diseases Unit Overview State

More information

All [HIV-exposed] infants should receive oral antiretroviral prophylaxis for the entire duration of breastfeeding - CON

All [HIV-exposed] infants should receive oral antiretroviral prophylaxis for the entire duration of breastfeeding - CON All [HIV-exposed] infants should receive oral antiretroviral prophylaxis for the entire duration of breastfeeding - CON Amy Slogrove Stellenbosch University 10 th International HIV Pediatrics Workshop

More information

PRIORITIES FOR HIV/AIDS PROCUREMENT AND PRODUCT DEVELOPMENT

PRIORITIES FOR HIV/AIDS PROCUREMENT AND PRODUCT DEVELOPMENT PRIORITIES FOR HIV/AIDS PROCUREMENT AND PRODUCT DEVELOPMENT Dr Chewe Luo MMed (Paeds), Mtrop Paed, PhD Senior Adviser and Team Leader Country Programme Scale up HIV Section Programme Division UNICEF, NY

More information

A Call to Action Children The missing face of AIDS

A Call to Action Children The missing face of AIDS A Call to Action Children The missing face of AIDS Scaling up Paediatric HIV Care Treatment in resource limited settings Dr Chewe Luo MMed(Paed); MTropPaed; PhD UNICEF Health Section Programme Division

More information

Evolving Realities of HIV Treatment in Resource-limited Settings

Evolving Realities of HIV Treatment in Resource-limited Settings Evolving Realities of HIV Treatment in Resource-limited Settings Papa Salif Sow MD, MSc Department of Infectious Diseases University of Dakar, Senegal Introduction: ARV access in RLS Scale-up of ART has

More information

Mother to Child HIV Transmission

Mother to Child HIV Transmission Koff WC. NEJM 2010;363:e7 Mother to Child HIV Transmission Why We Still Need New Prevention Modalities Lynne M. Mofenson, M.D. Maternal and Pediatric Infectious Disease Branch Eunice Kennedy Shriver National

More information

James Nuttall Paediatric Infectious Diseases Unit Red Cross Children s Hospital

James Nuttall Paediatric Infectious Diseases Unit Red Cross Children s Hospital James Nuttall Paediatric Infectious Diseases Unit Red Cross Children s Hospital Paediatric HIV Infection Symposium, August 21, 2010, Red Cross Children s Hospital Overview of talk The 2010 paediatric guidelines

More information

Michael Healy August 8, 2012 Irving CRC Research Proposal. 1. Study Purpose and Rationale

Michael Healy August 8, 2012 Irving CRC Research Proposal. 1. Study Purpose and Rationale Michael Healy August 8, 2012 Irving CRC Research Proposal Prevalence of diarrhea and gastrointestinal infection in severely malnourished Human Immunodeficiency Virus (HIV) infected children in Durban,

More information

TB & HIV CO-INFECTION IN CHILDREN. Reené Naidoo Paediatric Infectious Diseases Broadreach Healthcare 19 April 2012

TB & HIV CO-INFECTION IN CHILDREN. Reené Naidoo Paediatric Infectious Diseases Broadreach Healthcare 19 April 2012 TB & HIV CO-INFECTION IN CHILDREN Reené Naidoo Paediatric Infectious Diseases Broadreach Healthcare 19 April 2012 Introduction TB & HIV are two of the leading causes of morbidity & mortality in children

More information

Can we treat our way out of the HIV epidemic?

Can we treat our way out of the HIV epidemic? Can we treat our way out of the HIV epidemic? Richard E. Chaisson, MD Center for AIDS Research Center for TB Research Johns Hopkins University Schoolboy s (and politician s) tricks for evading the question

More information

Overview of Paediatric HIV Treatment and Prevention: From Then to Now. Peter Mugyenyi, Joint Clinical Research Centre Kampala, Uganda

Overview of Paediatric HIV Treatment and Prevention: From Then to Now. Peter Mugyenyi, Joint Clinical Research Centre Kampala, Uganda Overview of Paediatric HIV Treatment and Prevention: From Then to Now Peter Mugyenyi, Joint Clinical Research Centre Kampala, Uganda Outline The plight of HIV infected children (1980s and 1990s) Trends

More information

Pediatric Antiretroviral Therapy

Pediatric Antiretroviral Therapy Update on Pediatric Antiretroviral Therapy Lynne M. Mofenson, M.D. Pediatric, Adolescent and Maternal AIDS Branch National Institute of Child Health and Human Development National Institutes of Health

More information

TOWARDS ELIMINATION OF MOTHER TO CHILD TRANSMISSION OF HIV

TOWARDS ELIMINATION OF MOTHER TO CHILD TRANSMISSION OF HIV TOWARDS ELIMINATION OF MOTHER TO CHILD TRANSMISSION OF HIV Gladwel Muthoni KPA Conference 24 th April, 2018 OUTLINE Burden of HIV in PMTCT Mechanism and timing of Mother to Child Transmission (MTCT) Four

More information

OPPORTUNISTIC INFECTIONS. Institute of Infectious Diseases, Pune India

OPPORTUNISTIC INFECTIONS. Institute of Infectious Diseases, Pune India OPPORTUNISTIC INFECTIONS Institute of Infectious Diseases, Pune India DISCLOSURES Nothing to declare Outline The problem Bacterial Fungal Protozoal Viral Decline in OI prevalence in HAART era: USA CROI

More information

Infant feeding in the ARV era. Department of Obstetrics and Gynaecology Faculty of Health Sciences and Tygerberg Hospital

Infant feeding in the ARV era. Department of Obstetrics and Gynaecology Faculty of Health Sciences and Tygerberg Hospital Infant feeding in the ARV era Gerhard Theron Gerhard Theron Department of Obstetrics and Gynaecology Faculty of Health Sciences and Tygerberg Hospital Global HIV infections: 2007 12 countries account for

More information

Pediatric Antiretroviral Resistance Challenges

Pediatric Antiretroviral Resistance Challenges Pediatric Antiretroviral Resistance Challenges Thanyawee Puthanakit, MD The HIVNAT, Thai Red Cross AIDS research Center The Research Institute for Health Science, Chiang Mai University Outline The burden

More information

Dr HM Sebitloane Chief Specialist (Outreach) Dept of O+G NRMSM

Dr HM Sebitloane Chief Specialist (Outreach) Dept of O+G NRMSM Dr HM Sebitloane Chief Specialist (Outreach) Dept of O+G NRMSM SA Background Population: 48m Annual number of deliveries:1,2m 97% of women attend the first ANC 71% of women attend 5 th ANC visit 97% of

More information

Number of people receiving ARV therapy in developing and transitional countries by region,

Number of people receiving ARV therapy in developing and transitional countries by region, Progress in numbers The last six months have seen dramatic progress toward the 3 by 5 target. Between June and, the number of people receiving antiretroviral (ARV) therapy in developing and transitional

More information

Dr Graham P Taylor Reader in Communicable Diseases

Dr Graham P Taylor Reader in Communicable Diseases HIV in Pregnancy Joint RCOG/BHIVA Multidisciplinary Conference Dr Graham Taylor Imperial College London Friday 20 January 2012, Royal College of Obstetricians and Gynaecologist, London Prevention of post-partum

More information

Peter Elyanu 1, Addy Kekitiinwa 2,Rousha Li 1, Mary Paul 3, LY Hwang 1

Peter Elyanu 1, Addy Kekitiinwa 2,Rousha Li 1, Mary Paul 3, LY Hwang 1 OUTCOMES OF HIV EXPOSED INFANTS BEFORE AND AFTER IMPLEMENTING OPTION B+ PMTCT GUIDELINE IN KAMPALA,UGANDA: A RETROSPECTIVE COHORT STUDY. Peter Elyanu 1, Addy Kekitiinwa 2,Rousha Li 1, Mary Paul 3, LY Hwang

More information

The Global Fund s role as a strategic and responsible investor in HIV/AIDS: Paediatrics and PMTCT

The Global Fund s role as a strategic and responsible investor in HIV/AIDS: Paediatrics and PMTCT The Global Fund s role as a strategic and responsible investor in HIV/AIDS: Paediatrics and PMTCT Peter McDermott Managing Director, CIFF 19 th Board meeting, Geneva 6 th May 2009 Investment Criteria Measurable...change

More information

Updates on Revised Antiretroviral Treatment Guidelines Overview 27 March 2013

Updates on Revised Antiretroviral Treatment Guidelines Overview 27 March 2013 Updates on Revised Antiretroviral Treatment Guidelines 2013 Overview 27 March 2013 Introduction of Fixed Dose combination (FDC) FDCs will be available in facilities on 1 April 2013 The FDC ARV that will

More information

TB and HIV co-infection including IRIS

TB and HIV co-infection including IRIS TB and HIV co-infection including IRIS Richard Lessells SAHCS Conference 2018 Clinical scenario 1 36-year-old male Presents with cough, fever & weight loss HIV test positive (new diagnosis) Sputum Xpert

More information

HIV and Malaria Interactions

HIV and Malaria Interactions HIV and Malaria Interactions Dr. Moses R. Kamya Chair and Professor of Medicine Makerere University College of Health Sciences Kampala, Uganda INTEREST, Mombasa, Kenya 8 th -11 th May 2012 1 Outline Brief

More information

Program to control HIV/AIDS

Program to control HIV/AIDS 90-90-90 Program to control HIV/AIDS Hamid Sharifi Associate Professor in Epidemiology [sharifihami@gmail.com] 1 Targets for ending the AIDS epidemic 2 New HIV infections in low- and middle-income countries,

More information

HIV Clinical Management: Antiretroviral Therapy and Drug Resistance

HIV Clinical Management: Antiretroviral Therapy and Drug Resistance HIV Clinical Management: Antiretroviral Therapy and Drug Resistance Judith S. Currier, MD, MSc Professor of Medicine University of California, Los Angeles Disclosures: Research Grant from Theratechnologies

More information

2009 Recommendations for Antiretroviral Therapy in Adults and Adolescents. When to Start and What ART to Use in 1 st and 2 nd Line December 2009

2009 Recommendations for Antiretroviral Therapy in Adults and Adolescents. When to Start and What ART to Use in 1 st and 2 nd Line December 2009 2009 Recommendations for Antiretroviral Therapy in Adults and Adolescents When to Start and What ART to Use in 1 st and 2 nd Line December 2009 Historic Evolution of CD4 Criteria for ART Initiation in

More information

Infertility Treatment and HIV

Infertility Treatment and HIV Infertility Treatment and HIV Infertility Treatment by IVF Or Intra-cytoplasmic Sperm Injections (ICSC) In Chronic HIV-1 Sero- discordant Couples (Poster 670) Retrospective study of outcome of IVF or ICSC

More information

A Descriptive Study of Outcomes of Interventions to Prevent Mother to Child Transmission of HIV in Lusaka, Zambia

A Descriptive Study of Outcomes of Interventions to Prevent Mother to Child Transmission of HIV in Lusaka, Zambia ORIGINAL PAPER A Descriptive Study of Outcomes of Interventions to Prevent Mother to Child Transmission of HIV in Lusaka, Zambia Chibesa Shichitamba W, National Malaria Control Centre, Lusaka-Zambia ABSTRACT

More information

Dorothy Mbori-Ngacha UNICEF

Dorothy Mbori-Ngacha UNICEF THE DOUBLE DIVIDEND Action to improve survival of HIV exposed infected and uninfected children in the era of emtct and renewed child survival campaigns Dorothy Mbori-Ngacha UNICEF Outline The Double Dividend

More information

A smart and doable investment

A smart and doable investment 90-90-90 A smart and doable investment As of December 2013 Adults and children living with HIV Adults and children newly infected Adult & child deaths due to AIDS 35.0 million [33.2 million 37.2 million]

More information

targets for HIV-positive children

targets for HIV-positive children Accessing antiretroviral therapy (ART) is a matter of life and death for HIV-infected children. Without ART, half of children born with HIV die by the age of two years, and 80 percent die by the age of

More information

Breast Feeding for Women with HIV?

Breast Feeding for Women with HIV? Breast Feeding for Women with HIV? CHIVA / BHIVA Hermione Lyall Imperial Healthcare NHS Trust 17.11.17 Acknowledgements: Nell Freeman-Romilly, Pat Tookey, Claire Townsend, Claire Thorne, Kate Francis,

More information

Global AIDS New Developments in Care

Global AIDS New Developments in Care Global AIDS New Developments in Care Royce C. Lin, MD Assistant Clinical Professor of Medicine scope pledge delivery future Adults and children estimated to be living with HIV, 2005 Western & Eastern Europe

More information

Advances in HIV science and treatment. Report on the global AIDS epidemic,

Advances in HIV science and treatment. Report on the global AIDS epidemic, HIV biomolecular advances and treatment updates David A Cooper National Centre in HIV Epidemiology and Clinical Research The University of New South Wales Sydney, Australia UNAIDS: global l HIV infections

More information

The New National Guidelines. Feeding in the Context of HIV. Dr. Godfrey Esiru; National PMTCT Coordinator

The New National Guidelines. Feeding in the Context of HIV. Dr. Godfrey Esiru; National PMTCT Coordinator The New National Guidelines (2010) for PMTCT and Infant Feeding in the Context of HIV Dr. Godfrey Esiru; National PMTCT Coordinator Presentation outline Evolution of the PMTCT guidelines in Uganda Rational

More information

Care and Treatment of Children and Adolescents with HIV - The Barbados Experience.

Care and Treatment of Children and Adolescents with HIV - The Barbados Experience. Care and Treatment of Children and Adolescents with HIV - The Barbados Experience. M. Anne St John Consultant, Department of Paediatrics Queen Elizabeth Hospital, Barbados Hon Professor, Child Health,

More information

The Contribution of Family Planning towards the Prevention of HIV Mother-to-Child Transmission (PMTCT) in Uganda

The Contribution of Family Planning towards the Prevention of HIV Mother-to-Child Transmission (PMTCT) in Uganda The Contribution of Family Planning towards the Prevention of HIV Mother-to-Child Transmission (PMTCT) in Uganda Wolfgang Hladik CDC Uganda The findings and conclusions in this presentation are those of

More information

Young Mothers: From pregnancy to early motherhood in adolescents with HIV

Young Mothers: From pregnancy to early motherhood in adolescents with HIV Young Mothers: From pregnancy to early motherhood in adolescents with HIV Lisa L. Abuogi, MD, MSc Assistant Professor University of Colorado, Denver 8 th HIV and Women Workshop March 2, 2018 Boston, MA

More information

Towards universal access

Towards universal access Key messages Towards universal access Scaling up priority HIV/AIDS interventions in the health sector September 2009 Progress report Towards universal access provides a comprehensive global update on progress

More information

Review of recent changes in WHO and national paediatric care guidelines Dr. Chewe Luo UNICEF New York City, USA

Review of recent changes in WHO and national paediatric care guidelines Dr. Chewe Luo UNICEF New York City, USA Review of recent changes in WHO and national paediatric care guidelines Dr. Chewe Luo UNICEF New York City, USA Review of recent changes in WHO and national paediatric care guidelines Dr. Chewe Luo MMed

More information

Children infected with HIV

Children infected with HIV This Section describes the impact of HIV and AIDS on young children and the extent of the problem. It also provides an overview of how HIV is transmitted to infants and young children. HIV and AIDS can

More information

HIV Infection in Pregnancy. Francis J. Ndowa WHO RHR/STI

HIV Infection in Pregnancy. Francis J. Ndowa WHO RHR/STI HIV Infection in Pregnancy Francis J. Ndowa WHO RHR/STI FJN_STI_2005 Department of reproductive health and research Département santé et recherche génésiques Session outline Effect of pregnancy on HIV

More information

Paediatrics and adolescents

Paediatrics and adolescents Paediatrics and adolescents SAMU SUMMARIES January 2018 samumsf.org Objectives of this Presentation To describe epidemiology the global response to HIV in both populations: children and adolescents To

More information

Infant feeding and HIV Policy, Evidence and Hospital Challenges

Infant feeding and HIV Policy, Evidence and Hospital Challenges Infant feeding and HIV Policy, Evidence and Hospital Challenges Max Kroon MMH/SCAH MY BRIEF Overview of infant feeding within the PMTCT program including national policy, feeding choices & research evidence

More information

Investing for Impact Prioritizing HIV Programs for GF Concept Notes. Lisa Nelson, WHO Iris Semini, UNAIDS

Investing for Impact Prioritizing HIV Programs for GF Concept Notes. Lisa Nelson, WHO Iris Semini, UNAIDS Investing for Impact Prioritizing HIV Programs for GF Concept Notes Lisa Nelson, WHO Iris Semini, UNAIDS Top 5 Lessons Learned 1 2 3 4 5 Prioritize within the allocation amount Separate above allocation

More information

TRANSITION TO NEW ANTIRETROVIRALS IN HIV PROGRAMMES

TRANSITION TO NEW ANTIRETROVIRALS IN HIV PROGRAMMES POLICY BRIEF HIV TREATMENT TRANSITION TO NEW ANTIRETROVIRALS IN HIV PROGRAMMES JULY 2017 WHO This policy brief provides advice on a phased approach to transitioning to new WHO-recommended HIV treatment

More information

The Cumulative Incidence of HIV Infection in HIVexposed Infants with a Birth Weight of 1500g Receiving Breast Milk and Daily Nevirapine

The Cumulative Incidence of HIV Infection in HIVexposed Infants with a Birth Weight of 1500g Receiving Breast Milk and Daily Nevirapine The Cumulative Incidence of HIV Infection in HIVexposed Infants with a Birth Weight of 1500g Receiving Breast Milk and Daily Nevirapine A retrospective, descriptive study conducted at Kalafong hospital,

More information

PAEDIATRIC HIV INFECTION. Dr Ashendri Pillay Paediatric Infectious Diseases Specialist

PAEDIATRIC HIV INFECTION. Dr Ashendri Pillay Paediatric Infectious Diseases Specialist PAEDIATRIC HIV INFECTION Dr Ashendri Pillay Paediatric Infectious Diseases Specialist Paediatric HIV Infection Epidemiology Immuno-pathogenesis Antiretroviral therapy Transmission Diagnostics Clinical

More information

JOINT WHO/UNAIDS/UNICEF STATEMENT ON USE OF COTRIMOXAZOLE AS PROPHYLAXIS IN HIV EXPOSED AND HIV INFECTED CHILDREN

JOINT WHO/UNAIDS/UNICEF STATEMENT ON USE OF COTRIMOXAZOLE AS PROPHYLAXIS IN HIV EXPOSED AND HIV INFECTED CHILDREN JOINT WHO/UNAIDS/UNICEF STATEMENT ON USE OF COTRIMOXAZOLE AS PROPHYLAXIS IN HIV EXPOSED AND HIV INFECTED CHILDREN WHO, UNAIDS and UNICEF, guided by recent evidence, have agreed to modify as an interim

More information

Dr. Natella Rakhmanina Senior Technical Advisor, Elizabeth Glaser Pediatric AIDS Foundation October 2018

Dr. Natella Rakhmanina Senior Technical Advisor, Elizabeth Glaser Pediatric AIDS Foundation October 2018 Dr. Natella Rakhmanina Senior Technical Advisor, Elizabeth Glaser Pediatric AIDS Foundation October 2018 1 Number of young people living with HIV (aged 15 19 years) by mode of HIV acquisition, 25 countries,*

More information

WESTERN CAPE ART GUIDELINES PRESENTATION 2013

WESTERN CAPE ART GUIDELINES PRESENTATION 2013 WESTERN CAPE ART GUIDELINES PRESENTATION 2013 The WC guidelines are based on SA National ART guidelines dated 24th March 2013 Acknowledgement goes to members of the Adult and Paediatric HAST policy advisory

More information

Early Antiretroviral Therapy in Newborns: Opportunities and Challenges. Ellen Gould Chadwick MD Northwestern University Feinberg School of Medicine

Early Antiretroviral Therapy in Newborns: Opportunities and Challenges. Ellen Gould Chadwick MD Northwestern University Feinberg School of Medicine Early Antiretroviral Therapy in Newborns: Opportunities and Challenges Ellen Gould Chadwick MD Northwestern University Feinberg School of Medicine Conflict of Interest Disclosures for Ellen Chadwick MD

More information

Paediatric ART: eligibility criteria and first line regimens. (revised) Dave le Roux 13 August 2016

Paediatric ART: eligibility criteria and first line regimens. (revised) Dave le Roux 13 August 2016 Paediatric ART: eligibility criteria and first line regimens (revised) Dave le Roux 13 August 2016 Outline Eligibility criteria for starting ART Evolving evidence for earlier ART W Cape, National, WHO

More information

Antiretroviral therapy for adults and adolescents KEY MESSAGES. HIV/AIDS Department BACKGROUND

Antiretroviral therapy for adults and adolescents KEY MESSAGES. HIV/AIDS Department BACKGROUND KEY MESSAGES New WHO Recommendations: Antiretroviral therapy for adults and adolescents The World Health Organization (WHO) is revising its guidelines on antiretroviral therapy (ART) for adults and adolescents.

More information

Improving HIV/AIDS management in children:nutrition as a vital component

Improving HIV/AIDS management in children:nutrition as a vital component Prof Isaac K. Quay University of Botswana School of Medicine (codata:24-27 th Oct) Improving HIV/AIDS management in children:nutrition as a vital component Isaac K. Quaye, University of Botswana School

More information

2nd line failure, provincial evaluation process for 3rd line therapy, 3rd line treatment options James Nuttall

2nd line failure, provincial evaluation process for 3rd line therapy, 3rd line treatment options James Nuttall 2nd line failure, provincial evaluation process for 3rd line therapy, 3rd line treatment options James Nuttall Paediatric Infectious Diseases Unit, Red Cross War Memorial Children s Hospital & University

More information

1. Africa Centre for Health and Population Studies 2. London School of Hygiene and Tropical Medicine 3. University College London

1. Africa Centre for Health and Population Studies 2. London School of Hygiene and Tropical Medicine 3. University College London A systematic review of the effects of interrupted antiretroviral interventions for prevention of mother-to-child transmission of HIV on maternal disease progression and survival Naidu KK 1, Mori R 2, Newell

More information

HIV DRUG RESISTANCE AND STEWARDSHIP 3 RD LINE PROGRAMME

HIV DRUG RESISTANCE AND STEWARDSHIP 3 RD LINE PROGRAMME HIV DRUG RESISTANCE AND STEWARDSHIP 3 RD LINE PROGRAMME SOUTHERN AFRICAN HIV CLINICIANS SOCIETY CONFERENCE - 2014 26 SEPTEMBER 2014 Khadija Jamaloodien Affordable Medicines ANTIMICROBIAL STEWARDSHIP The

More information

Challenges of HIV drug resistance in resource-limited settings

Challenges of HIV drug resistance in resource-limited settings Challenges of HIV drug resistance in resource-limited settings Marie-Louise Newell Professor of Global Health Faculty of Medicine and Faculty of Social and Human Sciences, University of Southampton, UK

More information

Projected Demand for HIV Diagnostic Tests

Projected Demand for HIV Diagnostic Tests Projected Demand for HIV Diagnostic Tests John Stover, Yu Teng, Adebiyi Adesina, Eline Korenromp On behalf of the Diagnostics Forecasting Technical Working Group (CDC, CHAI, GFATM, PfSCM, UNAIDS, UNICEF,

More information

Rajesh T. Gandhi, M.D.

Rajesh T. Gandhi, M.D. HIV Treatment Guidelines: 2010 Rajesh T. Gandhi, M.D. Case 29 yo M with 8 weeks of cough and fever. Diagnosed with smear-positive pulmonary TB. HIV-1 antibody positive. CD4 count 361. HIV-1 RNA 23,000

More information

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN UNAIDS DATA TABLES 2011 Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN 978-92-9173-945-5 UNAIDS / JC2225E The designations employed and the presentation of

More information

XVII INTERNATIONAL AIDS CONFERENCE MEXICO CITY, 3-8 August 2008 SCALING-UP NATIONAL PMTCT PROGRAM

XVII INTERNATIONAL AIDS CONFERENCE MEXICO CITY, 3-8 August 2008 SCALING-UP NATIONAL PMTCT PROGRAM XVII INTERNATIONAL AIDS CONFERENCE MEXICO CITY, 3-8 August 2008 SCALING-UP NATIONAL PMTCT PROGRAM Phasing more efficacious ARV regimen for PMTCT in resource limited setting Lessons Learned from RWANDA

More information

WHO HIV Drug Resistance Strategy

WHO HIV Drug Resistance Strategy WHO HIV Drug Resistance Strategy Boston, 27 February 2011 Background Global ART scale-up has been a remarkable achievement benefiting over 5.2 million individuals in resource limited settings Maintaining

More information

Update on global guidelines. and emerging issues on perinatal HIV prevention. WHO 2013 Consolidated ARV Guidelines

Update on global guidelines. and emerging issues on perinatal HIV prevention. WHO 2013 Consolidated ARV Guidelines WHO 2013 Consolidated ARV Guidelines Update on global guidelines H I V / A I D S DEPARTMENT and emerging issues on perinatal HIV prevention Children & HIV, St. Petersburg, Russia Sept 25-26, 2014 Dr. Nathan

More information

Acquired HIV Drug Resistance in children in Asia

Acquired HIV Drug Resistance in children in Asia Acquired HIV Drug Resistance in children in Asia Jintanat Ananworanich, MD, PhD Pediatrician/Immunologist Deputy Director in Scientific Affairs, HIV-NAT Chief, SEARCH The Thai Red Cross AIDS Research Centre

More information

All HIV+ Women on Antiretroviral Therapy Should Breastfeed in Both Low and High Resource Settings VOTE NO!!

All HIV+ Women on Antiretroviral Therapy Should Breastfeed in Both Low and High Resource Settings VOTE NO!! All HIV+ Women on Antiretroviral Therapy Should Breastfeed in Both Low and High Resource Settings VOTE NO!! Lynne Mofenson MD Elizabeth Glaser Pediatric AIDS Foundation My Esteemed Opponent Will Likely

More information

GLOBAL HIV STATISTICS

GLOBAL HIV STATISTICS F A C T S H E E T W O R L D A I D S D A Y 2017 GLOBAL HIV STATISTICS 20.9 million people were accessing antiretroviral therapy in June 2017. 36.7 million [30.8 million 42.9 million] people globally were

More information

treatment during pregnancy and breastfeeding

treatment during pregnancy and breastfeeding treatment during pregnancy and breastfeeding Topics covered Introduction. Preventing parent-to-child transmission. AZT as a single therapy. Treatment begun late in pregnancy. Nevirapine for mothers and

More information

Effect of HAART on growth parameters and absolute CD4 count among HIV-infected children in a rural community of central Nigeria

Effect of HAART on growth parameters and absolute CD4 count among HIV-infected children in a rural community of central Nigeria Niger J Paed 2014; 41 (1): 1-6 Ebonyi AO Oguche S Dablets E Sumi B Yakubu E Sagay AS ORIGINAL Effect of HAART on growth parameters and absolute CD4 count among HIV-infected children in a rural community

More information

The promises & challenges of universal ART for women in southern Africa: Option B+ and beyond. Landon Myer

The promises & challenges of universal ART for women in southern Africa: Option B+ and beyond. Landon Myer The promises & challenges of universal ART for women in southern Africa: Option B+ and beyond Landon Myer 6 th International Workshop on HIV & Women 21 February 2015 Overview 1) Background Where are we?

More information

Second and third line paediatric ART strategies

Second and third line paediatric ART strategies Second and third line paediatric ART strategies Dr. Marape Marape Assistant Professor Ohio University School of Health Professions Gaborone, Botswana Marape Marape MB, BCh, BAO, MPH, PhD Assistant Professor

More information

The NEW ARV Guidelines FAQs

The NEW ARV Guidelines FAQs The NEW ARV Guidelines FAQs Dr Madeleine Muller MBChB (Pret).MRCGP(Lon).Dip Hiv Man IYDSA Clinical Advisor Acknowledgments IYDSA for materials and support NDOH for slides CDC our funder HIV Clinician Society

More information

AIDS at 25. Epidemiology and Clinical Management MID 37

AIDS at 25. Epidemiology and Clinical Management MID 37 AIDS at 25 Epidemiology and Clinical Management Blood HIV Transmission transfusion injection drug use Sexual Intercourse heterosexual male to male Perinatal intrapartum breast feeding Regional HIV and

More information

Current Status and Trends of Adolescent Health Care in Uganda

Current Status and Trends of Adolescent Health Care in Uganda Current Status and Trends of Adolescent Health Care in Uganda Dr.Sabrina Bakeera-Kitaka,MD Department of Paediatrics, Mulago National Referral Hospital, Kampala PATA 2010 Presentation Outline Introduction

More information

What is IRIS Types Outline of Presentation Principles behind Case definition of IRIS IRIS cause of early mortality IRIS a factor in optimal timing of

What is IRIS Types Outline of Presentation Principles behind Case definition of IRIS IRIS cause of early mortality IRIS a factor in optimal timing of Immune Reconstitution Inflammatory Syndrome: A factor in Timing of Initiation of ART Yunus Moosa UKZN Durban South Africa What is IRIS Types Outline of Presentation Principles behind Case definition of

More information

Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive

Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive DR. Nicholas Muraguri OGW, MD,MPH, MBA, PhD (c) Director, Global Plan Secretariat www.zero-hiv.org

More information

Introduction to Global Child Health Elective for Pediatric Residents and Fellows Children s National Medical Center, Washington, DC.

Introduction to Global Child Health Elective for Pediatric Residents and Fellows Children s National Medical Center, Washington, DC. Introduction to Global Child Health Elective for Pediatric Residents and Fellows Children s National Medical Center, Washington, DC October 11-15, 2010 Pre-Course Test 1. You are preparing for an elective

More information

Bone Mineral Density in a Cohort of Young Adult Women using Depoprovera and Tenofovir, Kampala, Uganda

Bone Mineral Density in a Cohort of Young Adult Women using Depoprovera and Tenofovir, Kampala, Uganda Bone Mineral Density in a Cohort of Young Adult Women using Depoprovera and Tenofovir, Kampala, Uganda Flavia Matovu Kiweewa, Noah Kiwanuka, Delia Scholes, Esther Isingel, Mary Glenn Fowler, Clemensia

More information

Elimination of New HIV Infections among Children by 2015 and Keeping their Mothers Alive:

Elimination of New HIV Infections among Children by 2015 and Keeping their Mothers Alive: Elimination of New HIV Infections among Children by 2015 and Keeping their Mothers Alive: Rationale for the call to action, progress to date and dealing with realities Rene Ekpini, MD, MPH Senior Adviser,

More information

Progress & challenges in PMTCT: The unfinished agenda

Progress & challenges in PMTCT: The unfinished agenda Progress & challenges in PMTCT: The unfinished agenda Dr Chewe Luo MMED (Paed); MTropPaed; PhD; FRCP Senior Adviser and Team Leader Country Programme Scale Up HIV Section, Programme Division UNICEF NY,

More information

Objectives. Outline. Section 1: Interaction between HIV and pregnancy. Effects of HIV on Pregnancy. Section 2: Mother-to-Child-Transmission (MTCT)

Objectives. Outline. Section 1: Interaction between HIV and pregnancy. Effects of HIV on Pregnancy. Section 2: Mother-to-Child-Transmission (MTCT) Objectives Prevention of Mother-to-Child Transmission (PMTCT) Teen Club Community Partners Training Programme By the end of the session participants will be able to: 1. Identify factors affecting the transmission

More information

In 2013, around 12.9 million people living with HIV had access to antiretroviral therapy.

In 2013, around 12.9 million people living with HIV had access to antiretroviral therapy. F A C T S H E E T 2014 GLOBAL STATISTICS People living with HIV In 2013, there were 35 [33.2 37.2 ] people living with HIV. - Since the start of the epidemic, around 78 [71 87 ] people have become infected

More information

ART for prevention the task ahead

ART for prevention the task ahead ART for prevention the task ahead Dr Teguest Guerma WHO/HQS WHO's role and vision Status of the epidemic Overview Progress and challenges in treatment and prevention scale up ART for prevention Questions

More information

WHO recommendations for HIVDR surveillance and their application in Latin America and the Caribbean

WHO recommendations for HIVDR surveillance and their application in Latin America and the Caribbean WHO recommendations for HIVDR surveillance and their application in Latin America and the Caribbean Giovanni Ravasi Pan-American Health Organization, Brazil ravasigi@paho.org Regional Consultation on HIV

More information

Accelerating Children s HIV Treatment (ACT): Rationale, Progress & Challenges

Accelerating Children s HIV Treatment (ACT): Rationale, Progress & Challenges Accelerating Children s HIV Treatment (ACT): Rationale, Progress & Challenges George Siberry, MD, MPH OGAC Senior Technical Advisor for Pediatrics March, 2016 Compared to Adults, Children (

More information

ANTIRETROVIRAL THERAPY IN NAMIBIA

ANTIRETROVIRAL THERAPY IN NAMIBIA ANTIRETROVIRAL THERAPY IN NAMIBIA SAHIVCS CONFERENCE CAPETOWN 25-28- NOVEMBER 2012 DR. F. MUGALA MUKUNGU M.MED (INT.MED) SPECIALIST PHYSICIAN KATUTURA STATE HOSPITAL WINDHOEK NAMIBIA Current status in

More information

AIDS at 30 Epidemiology and Clinical Epidemiology and Management MID 37

AIDS at 30 Epidemiology and Clinical Epidemiology and Management MID 37 AIDS at 30 Epidemiology and Clinical Management Blood HIV Transmission transfusion injection drug use Sexual Intercourse heterosexual male to male Perinatal intrapartum breast feeding Adults and children

More information

GLOBAL STATISTICS FACT SHEET 2015

GLOBAL STATISTICS FACT SHEET 2015 FACT SHEET 2015 GLOBAL STATISTICS 15.8 people accessing antiretroviral therapy (June 2015) 36.9 [34.3 41.4 ] people globally were living with HIV (end 2014) 2 [1.9 2.2 ] people became newly infected with

More information

Medical Challenges of HIV/AIDS pandemic: The WHO perspective. SOLTHIS HIV Forum

Medical Challenges of HIV/AIDS pandemic: The WHO perspective. SOLTHIS HIV Forum Medical Challenges of HIV/AIDS pandemic: The WHO perspective SOLTHIS HIV Forum Marco Vitoria HIV/AIDS Department World Health Organization September 2013 Topic 2002 2003 2006 2010 2013 When to start 1

More information

Optimizing 2 nd and 3 rd Line Antiretroviral Therapy in Children and Adolescents

Optimizing 2 nd and 3 rd Line Antiretroviral Therapy in Children and Adolescents Optimizing 2 nd and 3 rd Line Antiretroviral Therapy in Children and Adolescents Victor Musiime, MBChB, MMED, PhD Senior Lecturer, Makerere University Investigator, Joint Clinical Research Centre (JCRC)

More information

Outline. Aim with PMTCT. How are children transmitted. Prevention of mother-to-child transmission of HIV. How does HIV transmit to children?

Outline. Aim with PMTCT. How are children transmitted. Prevention of mother-to-child transmission of HIV. How does HIV transmit to children? Prevention of mother-to-child transmission of HIV Outline AimofPMTCT How HIV is transmitted to children Epidemiology of HIV in children How to reduce HIV transmission to children Guidelines Lars T. Fadnes

More information